Overview
Francesco Gelsomino practices practicing medicine in Bologna, Italy.
Mr. Gelsomino is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
He is actively involved in clinical research, co-authoring 129 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Francesco Gelsomino
Is Francesco Gelsomino a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Francesco Gelsomino is classified as an Distinguished expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Francesco Gelsomino participate in research or clinical trials?
Yes. Francesco Gelsomino has published 129 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Francesco Gelsomino's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Gelsomino isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Gelsomino isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerMr. Gelsomino isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung MetastasesMr. Gelsomino isAdvanced. Learn about Lung Metastases.
- Small Cell Lung Cancer (SCLC)Mr. Gelsomino isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Tubular NecrosisMr. Gelsomino isExperienced. Learn about Acute Tubular Necrosis.
- Anaplastic Large Cell LymphomaMr. Gelsomino isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Bone TumorMr. Gelsomino isExperienced. Learn about Bone Tumor.
- Brachial PlexopathyMr. Gelsomino isExperienced. Learn about Brachial Plexopathy.
- Cerebral HypoxiaMr. Gelsomino isExperienced. Learn about Cerebral Hypoxia.
- CholangitisMr. Gelsomino isExperienced. Learn about Cholangitis.
- Interstitial NephritisMr. Gelsomino isExperienced. Learn about Interstitial Nephritis.
- Li-Fraumeni SyndromeMr. Gelsomino isExperienced. Learn about Li-Fraumeni Syndrome.
- Lung AdenocarcinomaMr. Gelsomino isExperienced. Learn about Lung Adenocarcinoma.
- MelanomaMr. Gelsomino isExperienced. Learn about Melanoma.
- MononucleosisMr. Gelsomino isExperienced. Learn about Mononucleosis.
- Neuroendocrine TumorMr. Gelsomino isExperienced. Learn about Neuroendocrine Tumor.
- Renal Cell Carcinoma (RCC)Mr. Gelsomino isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Squamous Cell Lung CarcinomaMr. Gelsomino isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Thyroid NoduleMr. Gelsomino isExperienced. Learn about Thyroid Nodule.